Tryptophan extends the life of cytochrome P450
Open Access
- 7 December 2023
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (50)
Abstract
Powerfully oxidizing enzymes need protective mechanisms to prevent self-destruction. The flavocytochrome P450 BM3 from Priestia megaterium (P450 BM3 ) is a self-sufficient monooxygenase that hydroxylates fatty acid substrates using O 2 and NADPH as co-substrates. Hydroxylation of long-chain fatty acids (≥C 14 ) is well coupled to O 2 and NADPH consumption, but shorter chains (≤C 12 ) are more poorly coupled. Hydroxylation of p -nitrophenoxydodecanoic acid by P450 BM3 produces a spectrophotometrically detectable product wherein the coupling of NADPH consumption to product formation is just 10%. Moreover, the rate of NADPH consumption is 1.8 times that of O 2 consumption, indicating that an oxidase uncoupling pathway is operative. Measurements of the total number of enzyme turnovers before inactivation (TTN) indicate that higher NADPH concentrations increase TTN. At lower NADPH levels, added ascorbate increases TTN, while a W96H mutation leads to a decrease. The W96 residue is about 7 Å from the P450 BM3 heme and serves as a gateway residue in a tryptophan/tyrosine (W/Y) hole transport chain from the heme to a surface tyrosine residue. The data indicate that two oxidase pathways protect the enzyme from damage by intercepting the powerfully oxidizing enzyme intermediate (Compound I) and returning it to its resting state. At high NADPH concentrations, reducing equivalents from the flavoprotein are delivered to Compound I by the usual reductase pathway. When NADPH is not abundant, however, oxidizing equivalents from Compound I can traverse a W/Y chain, arriving at the enzyme surface where they are scavenged by reductants. Ubiquitous tryptophan/tyrosine chains in highly oxidizing enzymes likely perform similar protective functions.Keywords
Funding Information
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK019038)
- Arnold and Mabel Beckman Foundation (Not applicable)
This publication has 54 references indexed in Scilit:
- Peroxidase-like activity of uncoupled cytochrome P450Biochemical Pharmacology, 2012
- P450BM3(CYP102A1): connecting the dotsChemical Society Reviews, 2011
- Microaerobic steroid biosynthesis and the molecular fossil record of Archean lifeProceedings of the National Academy of Sciences, 2011
- Cytochrome P450 Compound I: Capture, Characterization, and C-H Bond Activation KineticsScience, 2010
- Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coliNature Chemical Biology, 2009
- How Do Enzymes Activate Oxygen without Inactivating Themselves?Accounts of Chemical Research, 2007
- Mechanism of O2 Activation by Cytochrome P450cam Studied by Isotope Effects and Transient State KineticsBiochemistry, 2006
- Electron Transfer between the FMN and Heme Domains of Cytochrome P450BM-3Journal of Biological Chemistry, 1997
- Uncoupling Oxygen Transfer and Electron Transfer in the Oxygenation of Camphor Analogues by Cytochrome P450-CAMJournal of Biological Chemistry, 1995
- ω-1, ω-2 and ω-3 Hydroxylation of long-chain fatty acids, amides and alcohols by a soluble enzyme system from Bacillus megatyeriumBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1975